InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Soland Daniel B, 首席运营官. Officer active across 3 companies, notably Idera Pharmaceuticals, INC.. Aggregated, 5 reports have been recorded. Split: 2 buys · 0 sell. Total volume traded: €72k. History available since 18 June 2021. The latest transaction was filed on 1 August 2023 (Acquisition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Daniel B. Soland is the Chief Operating Officer of IDERA PHARMACEUTICALS, INC. In this role, he is responsible for managing the daily operations of the company. His expertise in the pharmaceutical sector and ability to lead teams enable him to optimize operational processes and improve efficiency.